Skip to main content
. 2021 Nov 24;57(12):1293. doi: 10.3390/medicina57121293

Figure 3.

Figure 3

Changes in the best corrected visual acuity during individual follow-up visits—comparison of Aflibercept and Ranibizumab treatment results. The course of the best corrected visual acuity curve is much flatter for the group receiving Ranibizumab.